The Food and Drug Administration identified the recall of Medtronic's MiniMed 600 Series Insulin Pumps as a "Class I" recall. This is the most serious type of recall and means that use of such ...

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. | ...

Back to Healio Medtronic expanded a recall of remote controllers used with MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps due to potential cybersecurity risks ...

Medtronic announced today that it selected "MiniMed" as the name for its Diabetes unit following its planned separation.

Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean ...

Medtronic is recalling several models of its MiniMed insulin pumps because of a risk that hackers could take control and change their settings. The FDA said diabetics should talk with their ...

All Medtronic MiniMed 600 and 700 series insulin pumps have been recalled due to an increased risk for short battery life. Shortened battery life could cause insulin therapy to stop and lead to ...

The Food and Drug Administration (FDA) has approved design changes and a new programming interface for Medtronic's SynchroMed II implantable drug pump, months after federal authorities lifted ...

Medtronic is set to acquire EOFlow, the South Korea-based maker of an insulin patch pump. In its announcement of the deal Thursday, Medtronic suggested that integrating the tubeless device with ...